University of Verona-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2020

  1. Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

    Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 2, pp. 300-306

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

2014

  1. Flow cytometry in mastocytosis: Utility as a diagnostic and prognostic tool

    Immunology and Allergy Clinics of North America, Vol. 34, Núm. 2, pp. 297-313

  2. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM

    Journal of Allergy and Clinical Immunology, Vol. 133, Núm. 2

2013

  1. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

    Histopathology, Vol. 63, Núm. 6, pp. 780-787

  2. Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis

    Journal of Allergy and Clinical Immunology